
Rishi Singh, MD, reports on results from the VISTA and VIVID studies analyzing the use of intravitreal aflibercept injections to treat DME.


Rishi Singh, MD, reports on results from the VISTA and VIVID studies analyzing the use of intravitreal aflibercept injections to treat DME.

Caroline Baumal, MD, highlights results from the Phase 3 YOSEMITE and RHINE trials, providing an overview of the efficacy, safety and durability of faricimab in DME.

Dr Caroline Baumal provides an overview of the efficacy, safety and durability of faricimab in diabetic macular oedema (DMO) at ASRS 2021.

At the ASRS 39th Annual Scientific Meeting, Dr W. Lloyd Clark discusses retinal nonperfusion and leakage areas when managing patients with nonproliferative diabetic retinopathy in context of the results of the PANORAMA study.

W. Lloyd Clark, MD, presents results of the nonproliferative diabetic retinopathy-focused PANORAMA study during the 2021 ASRS annual meeting.

Proposal hints at the use of generative adversarial network (GAN) for applications in macular surgery.

The EIDON Ultra-Widefield Lens module from iCare USA has received 510(k) approval from the FDA for distribution in the US.

Swept-source optical coherence tomography angiography can detect eyes at risk of developing exudative disease.

Trial results indicate that retinal cell injections improve vision in certain retinitis pigmentosa patients.

Researchers consider frequency and factors in etiology of complication

Pilot study shows promise of teaching surgeons with technology.

Study: Older age and eyes with severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy had a higher risk of a vision loss event.

Graybug Vision reported Tuesday a full-data analysis from the phase 2b ALTISSIMO trial of GB-102 for the treatment of wet AMD.

American Society of Retina Specialists (ASRS) meeting offers scientific sessions, symposia, discussion groups, opportunities for attendees.

American Society of Retinal Specialists program to drive awareness and action around retinal diseases that put millions at risk for blindness.

Orbis, with support from FedEx, is offering training that will develop ophthalmologists’ skills to treat diabetic retinopathy in China.

Subtle changes in the retina, optic nerve and visual processing system may reveal early signs of Alzheimer’s disease and enable prompt initiation of treatment.

Future investigations will assess findings, evaluate their prognostic value.

Technology can track the progression of retinal abnormalities

The company will host Innovation Week from Sept. 21-23, demonstrating new data management innovations across devices, workflow solutions and software applications.

Scanning laser ophthalmoscopy offers improved view of posterior segment.

Pilot study shows promise of teaching surgeons with technology.

A post-conference guide for ophthalmologists after the conclusion of EURETINA 2021.

AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.

Development of new animal model enhances study of genetic mutations.